Related Experiment Video

Updated: Mar 11, 2026

Implantation of Total Artificial Heart in Congenital Heart Disease
07:27

Implantation of Total Artificial Heart in Congenital Heart Disease

Published on: July 18, 2014

25.3K

[Device treatment in adults with congenital heart defects]

Adrian Reinhardt1, Götz Buchwalsky2, Leon Iden3

  • 1Elektrophysiologie Bremen, Herzzentrum Bremen am Klinikum Links der Weser, Senator-Wessling-Strasse 1, 28277, Bremen, Deutschland. a.reinhardt@ep-bremen.de.

Herzschrittmachertherapie & Elektrophysiologie
|March 9, 2026
PubMed

Insights

Implanting cardiac devices in patients with congenital heart defects is challenging due to complex anatomy. This review offers a practical guide for successful pacemaker or defibrillator implantation in these complex cases.

Area of Science:

  • Cardiology
  • Congenital Heart Disease
  • Medical Device Implantation

Background:

  • Cardiac implantable device procedures in patients with congenital heart defects present significant anatomical challenges.
  • These procedures require careful planning and execution by specialized interdisciplinary teams.
  • Centers experienced in complex congenital heart disease are crucial for successful outcomes.

Purpose of the Study:

  • To provide a practical guide for performing pacemaker or defibrillator implantation in patients with complex congenital heart defects.
  • To outline strategies for managing anatomical complexities during device implantation.
  • To share insights based on representative case examples.

Main Methods:

  • Review of existing literature and clinical guidelines.
  • Analysis of representative case studies of pacemaker and defibrillator implantation in complex congenital heart defects.
  • Emphasis on interdisciplinary team collaboration and specialized center protocols.

Main Results:

  • Successful implantation is achievable with meticulous planning and tailored approaches.
  • Management of complex anatomy requires specific techniques and careful device selection.
  • Interdisciplinary collaboration is key to mitigating risks and optimizing patient care.

Conclusions:

  • Pacemaker and defibrillator implantation in complex congenital heart defects can be performed successfully.
  • A practical, case-based approach guides successful device implantation in this challenging population.
  • Specialized centers and interdisciplinary teams are essential for optimal patient outcomes.

Keywords:
Comlpex heart defectsConduction system pacingCongential heart diseaseImplantable cardioverter defibrillatorPacemaker

More Related Videos

A Simplified Model for Heterotopic Heart Valve Transplantation in Rodents06:33

A Simplified Model for Heterotopic Heart Valve Transplantation in Rodents

Published on: September 21, 2021

2.8K
Implantation of the Syncardia Total Artificial Heart16:11

Implantation of the Syncardia Total Artificial Heart

Published on: July 18, 2014

36.2K

Related Concept Videos

Heart Failure VI: Adjunct Therapies01:22

Heart Failure VI: Adjunct Therapies

Additional therapies for treating patients with heart failure (HF) may include procedural interventions, supplemental oxygen, the management of sleep disorders, and nutritional therapy.Procedural InterventionsImplantable Cardioverter-Defibrillator: For patients at risk of life-threatening arrhythmias due to severe left ventricular dysfunction, an Implantable Cardioverter-Defibrillator (ICD) can detect and terminate these arrhythmias, preventing sudden cardiac death and improving survival rates.
494
Cardiomyopathy V: Interprofessional Care01:29

Cardiomyopathy V: Interprofessional Care

Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...
566
Cardiomyopathy II: Dilated Cardiomyopathy01:30

Cardiomyopathy II: Dilated Cardiomyopathy

Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...
695
Rheumatic Heart Disease III: Medical Management01:21

Rheumatic Heart Disease III: Medical Management

Rheumatic heart disease (RHD) management can be divided into two main strategies: prevention and long-term management.Primary PreventionPrimary prevention focuses on timely diagnosis and management of group A streptococcal pharyngitis to prevent acute rheumatic fever. The most widely used antibiotic for treating this condition is intramuscular benzathine penicillin G.Acute Rheumatic Fever TreatmentThe primary treatment goal for a patient diagnosed with acute rheumatic fever is to suppress the...
445
Cardiomyopathy III: Hypertrophic Cardiomyopathy01:29

Cardiomyopathy III: Hypertrophic Cardiomyopathy

Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
603
Mitral Stenosis III: Medical Management01:26

Mitral Stenosis III: Medical Management

Mitral stenosis, a condition marked by the narrowing of the mitral valve, necessitates an integrated approach for effective management. This approach includes preventative measures, medical therapy, and surgical interventions to reduce symptoms and prevent complications.PreventionPrevention of mitral stenosis primarily focuses on reducing the incidence of bacterial infections, particularly streptococcal infections, which can lead to rheumatic fever and subsequent valvular damage. Timely...
404